News

Send link
NUMBER OF HITS: 29
Börse Nasdaq
12.10.2019

BioNTech SE from Mainz has successfully made the leap to the American technology exchange Nasdaq. The company made its debut on the stock exchange and raised 150 million US-dollars.

09.09.2019

The Mainz-based biotech company BioNTech SE does not lack in prominent investors. The Bill and Melinda Gates Foundation is now investing $55 million.  And the amount can still grow to $100 million.

Goldmünzen
11.07.2019

Once again, the Mainz-based company BioNTech has secured a sum in the hundred-million-euro range. Two thirds of the capital was contributed by new investors.

Krebszellen
20.06.2019

BioNTech SE announces the start of clinical development for its drug candidate DuoBody PD-L1x4-1BB.

Bakterien
12.06.2019

With the help of investors both new and old, the Freiburg-based start-up is taking the next big step in the introduction of its innovative technology for the rapid detection of multi-resistant germs.

Zecke - Holzbock
18.04.2019

The "vaccination against tick bites" of the Norden Vaccines team is among the winners of the Innovation Prize of the Bioregions of Germany 2019.

Headquarter BioNTech AG in Mainz
19.03.2019

Rumors have it that BioNTech is preparing for an IPO on the US technology exchange Nasdaq. According to Reuters, the company has entrusted two US banks with the preparations.

Nervenzellen
13.03.2019

CorTec GmbH was again included in this year's list of the most innovative companies in Germany. It had already been honored in 2018.

Professor Ugur Sahin erhält Deutschen Krebspreis
04.03.2019

For his work on cancer immunotherapies, Professor Ugur Sahin, founder and CEO of BioNTech AG, was honored with this year's German Cancer Award.

Aufnahme des Darms im bildgebenden Verfahren
15.02.2019

The EU consortium led by iThera Medical is funded by the European Fast Track to Innovation programme. The aim is to advance the so-called MSOT technology.

18.01.2019

Since 2015, BioNTech AG and Sanofi have been partners in the development of cancer therapies. The cooperation is now being extended with an investment of 80 million euros.

17.12.2018

Freiburg-based SpinDiag GmbH succeeds in concluding a series A round on 3 million euros. The funds will be used to start clinical validation in Europe.

19.11.2018

Berlin-based Omeicos Therapeutics GmbH receives 17 million euros to advance the clinical testing of its substance for the treatment of cardiac arrhythmia.

Krebszellen
30.10.2018

The peptide-based cancer drug AMC303 from the biotech company amcure GmbH has shown good tolerability in initial clinical studies.

02.10.2018

The next GO-Bio Investmentlounge is just around the corner: around 80 participants – among them investors and founding teams – are expected to join the event on 08 - 09 November near Berlin.

Geldscheine Euroscheine
18.09.2018

The Munich-based medical technology start-up iThera Medical GmbH raised 7 million euros in mid-September. The capital will be used chiefly to finance clinical studies.

Impfstoff-Ampullen
17.08.2018

BioNTech AG has forged another top-class alliance with a large pharmaceutical company: together with Pfizer, the Mainz-based company plans to develop novel flu vaccines.

09.08.2018

After successful funding, the start-up company Purenum has started its work. The aim is to further develop the biocompatible medical adhesive developed in the GO-Bio project mediNik.

Biomarker
26.07.2018

The Pro-Detekt research group based at the Life Science Incubator (LSI) in Saxony was able to extend its patent protection for the key PRET-ELISA technology to the USA.

Preisträger des GO-Bio-Wettbewerbs 2018
18.04.2018

The GO-Bio winners for 2018 have been named: Eight start-up teams took home awards from the biotechnology conference in Berlin. They will each receive funding running into millions of euros from the BMBF.

Back to top of page